Proposed BIOSECURE Act Could Impact U.S. Companies' Contracts With Chinese Biotech Firms Amid National Security Threats and COVID's Origins

The Wall Street Journal@WSJ

2 years ago

Heard on the Street: A proposed bill in Congress targets Chinese biotech firms, posing a threat to U.S. drug companies’ supply chains https://t.co/hnjLLWiVBV https://t.co/hnjLLWiVBV

Congress Sets Sights on Limiting Access to Chinese Biotech Companies https://t.co/B8lMUOXbDA | by @pillsburylaw

If you do research in #biotech, #genomics or other life sciences - keep an eye on the bipartisan @USCongress H.R.7085 - BIOSECURE Act, which is currently been refererred to committee for review. 🦠🔬🧪🧫 Could have massive impact on global research. https://t.co/Lrv2QV6VJh